Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant, Cherry Lime Rickey) as well as an ongoing Pharmaceutical Development initiative (Proposed Anti-Nausea Product).
Management Team
Seth M. Shaw
Chief Executive Officer
Mr. Shaw has extensive experience building companies and
securing financing from a broad array of both domestic and
international institutional investors…
Mr. Shaw has extensive experience building companies
and securing financing from a broad array of both
domestic and international institutional investors.
Over the past fifteen years, he has been instrumental
in securing more than $100 million in capital, in
aggregate, for a number ofl small-cap and micro-cap
companies (both publicly traded and privately held).
Mr. Shaw started his career at American
International Group (AIG) Global Investment Group,
after which he gained further experience working at a
prestigious Manhattan based hedge fund. In 2005, he
founded Novastar Resources Ltd, a natural resources
exploration company focused on the exploration and
acquisition of mineral properties containing the
element thorium (Th). During this period, Mr. Shaw
secured more than $17 million in financing from top
tier institutional investors and helped complete the
merger between Novastar Resources and Thorium Power,
holding the position of Director of Strategic Planning
until mid-2007. Subsequently, the company changed its
name to Lightbridge Inc. and currently trades on the
NASDAQ - under the ticker symbol: LTBR.
Following
the above-referenced merger, Mr. Shaw has assisted
several other companies in securing value added
capital from institutional investors as well as
providing management consulting services. Among those,
Mr. Shaw was instrumental in securing $12,000,000 for
a NASDAQ listed flat panel color display
developer. In addition Mr. Shaw served as the
founding CFO of a Los Angeles based Biotech firm which
announced plans for a $118 million NASDAQ IPO in
February of 2011.
More recently Mr. Shaw
has served as President and CEO of OTCQB Listed
Tauriga Sciences Inc., since July 2015, during which
time he secured a $2,000,000+ cash Settlement
(Insurance Settlement) for the Company and launched
its Tauri-Gum™ product line (Proprietary – Cannabidiol
-CBD- & Cannabigerol -CBG- Infused Chewing Gum).
The Tauri-Gum™ product line consists of 7
distinct flavors/versions: Pomegranate, Blood Orange,
Peach-Lemon, Pear Bellini, Mint, Black Currant, Cherry
Lime Rickey. He has created a multi faceted
business model for Tauriga that has resulted in both
revenue growth, vertical opportunities, and a strong
balance sheet. Also during his period, Mr. Shaw
has served as a Consultant for a NASDAQ listed Biotech
firm developing a novel drug candidate for the
treatment of Major Depressive Disorder.
Mr. Shaw graduated from Cornell University
in 2001, with a degree in Policy Analysis Management
and a concentration in Econometrics. Mr. Shaw has
served on the Board of Directors of a number of
important entities and initiatives, including but not
limited to: the Jewish Community Center (JCC) of
Dutchess County NY (2005-2015), Save A Child’s Heart
(“SACH”) New York City Leadership Group (2012-2017),
The Cypress Fund for World Peace and Security
(2006-2010), and has been active in numerous charities
and not for profits, including: The Robinhood
Foundation (2007-2009).

Kevin Lacey
Chief Financial Officer
Kevin Lacey is an experienced finance professional with
over twenty year’s experience working with small and large
companies leading financial teams, implementing…
Kevin Lacey is an experienced finance professional
with over twenty year’s experience working with small
and large companies leading financial teams,
implementing and converting accounting systems,
designing and implementing controls, inventory system
implementation and management as well as vast
experience in preparing financial statements,
budgeting and financial analysis.
Over the
past five years, Kevin, as head of Mariner Consulting
Group Inc., has worked with numerous small reporting
public companies in financial statement preparation
and consulting as well as assisting many small private
companies with accounting system design and
implementation along with business development
consulting.
Kevin is a Certified Public
Accountant (CPA) as registered with the State of
Florida. He holds a Masters in Business Administration
(MBA) from that University of Central Florida (1999)
as well as a Bachelors in the Science of Accounting
from Webber International University (1993).
Kevin is also an U.S. Military Veteran,
serving in the U.S. Army from 1987 to 1989. He was
honorably discharged in 1989.

Adina Miles
Chief Marketing Officer
Adina Miles initially gained notoriety in the marketing
world by developing the satirical persona FlatbushGirl and
garnering tens of thousands of social…
Adina Miles initially gained notoriety in the
marketing world by developing the satirical persona
FlatbushGirl and garnering ten of thousands of social
media followers and millions of video views. Since
then, she has spearheaded marketing projects for
political campaigns, consulted with numerous
businesses on social media strategies, and has
received front page news press through her activism of
women’s rights.
Adina was initially brought in to grow the Tauri-Gum
B2C e-commerce presence and has since moved into
product development and raising additional capital for
Tauriga Sciences.
In her free time, Adina is a political and
social activist, social media influencer, and a
volunteer EMT.

Dr Keith Aqua
Chief Medical Officer
As Chief Medical Officer, Keith A. Aqua, MD brings more than 25 years of industry experience as a private practitioner and certified clinical investigator to Tauriga Sciences… As Chief Medical Officer, Keith A. Aqua, MD brings more than 25 years of industry experience as a private practitioner and certified clinical investigator to Tauriga Sciences. Alongside his clinical research, Dr. Aqua is a board-certified obstetrician/gynecologist with a thriving private practice in West Palm Beach, Florida. He received a B.A. from the University of Pennsylvania and an M.D. from The Ohio State University. After completing his residency at the University of Arizona Health Sciences Center, he co-founded the Institute for Women’s Health and Body, a large single specialty group located in Palm Beach County, Florida. In 2001, he founded Visions Clinical Research and in 2015 the Atlantic Clinical Research Collaborative. He has been a Principal Investigator on over 300 pharmaceutical industry-sponsored clinical trials. He has received numerous teaching awards and has a number of publications and citations related to research in women’s health, dermatology, and family medicine. He is currently a speaker for several pharmaceutical companies and is an adjunct clinical professor at the Charles E. Schmidt College of Medicine at Florida Atlantic University.
Board of Directors

Seth M. Shaw
Mr. Shaw has extensive experience building companies
and securing financing from a broad array of both
domestic and international institutional
investors…
Mr. Shaw has extensive experience building
companies and securing financing from a broad
array of both domestic and international
institutional investors. Over the past fifteen
years, he has been instrumental in securing more
than $100 million in capital, in aggregate, for a
number ofl small-cap and micro-cap companies (both
publicly traded and privately held).
Mr. Shaw started his career at
American International Group (AIG) Global
Investment Group, after which he gained further
experience working at a prestigious Manhattan
based hedge fund. In 2005, he founded Novastar
Resources Ltd, a natural resources exploration
company focused on the exploration and acquisition
of mineral properties containing the element
thorium (Th). During this period, Mr. Shaw secured
more than $17 million in financing from top tier
institutional investors and helped complete the
merger between Novastar Resources and Thorium
Power, holding the position of Director of
Strategic Planning until mid-2007. Subsequently,
the company changed its name to Lightbridge Inc.
and currently trades on the NASDAQ - under the
ticker symbol: LTBR.
Following the
above-referenced merger, Mr. Shaw has assisted
several other companies in securing value added
capital from institutional investors as well as
providing management consulting services. Among
those, Mr. Shaw was instrumental in securing
$12,000,000 for a NASDAQ listed flat panel color
display developer. In addition Mr. Shaw
served as the founding CFO of a Los Angeles based
Biotech firm which announced plans for a $118
million NASDAQ IPO in February of 2011.
More
recently Mr. Shaw has served as President and CEO
of OTCQB Listed Tauriga Sciences Inc., since July
2015, during which time he secured a $2,000,000+
cash Settlement (Insurance Settlement) for the
Company and launched its Tauri-Gum™ product line
(Proprietary – Cannabidiol -CBD- & Cannabigerol
-CBG- Infused Chewing Gum). The Tauri-Gum™
product line consists of 7 distinct
flavors/versions: Pomegranate, Blood Orange,
Peach-Lemon, Pear Bellini, Mint, Black Currant,
Cherry Lime Rickey. He has created a
multi faceted business model for Tauriga that has
resulted in both revenue growth, vertical
opportunities, and a strong balance sheet.
Also during his period, Mr. Shaw has served as a
Consultant for a NASDAQ listed Biotech firm
developing a novel drug candidate for the
treatment of Major Depressive Disorder.
Mr. Shaw graduated from Cornell
University in 2001, with a degree in Policy
Analysis Management and a concentration in
Econometrics. Mr. Shaw has served on the Board of
Directors of a number of important entities and
initiatives, including but not limited to:
the Jewish Community Center (JCC) of
Dutchess County NY (2005-2015), Save A Child’s
Heart (“SACH”) New York City Leadership Group
(2012-2017), The Cypress Fund for World Peace and
Security (2006-2010), and has been active in
numerous charities and not for profits, including:
The Robinhood Foundation (2007-2009).

Thomas Graham
Director of Operations for Sears and Roebuck a
national retailer with stores nation wide. Over see
direct operations for all departments their managers
and…
Director of Operations for Sears and Roebuck a
national retailer with stores nation wide. Over
see direct operations for all departments their
managers and associates. Accountable for all
sales, labor and operation standards as set by
Sears Corporate. Results oriented Marketing and
Sales Director for a major Michigan retail
supermarket with sales in excess of
$100,000,000.00 annually. Over see all print and
visual advertising including newspaper, radio and
television. Work with local and national vendors
to promote and increase sales and customer flow.
Store Manager with successful experience managing
multiple unit organizations.
Analyzed
market conditions, buying trends and competitor
challenges to gain market share. Recruited,
trained and developed employees and built self
sustaining teams to ensure customer satisfaction.
Exceed yearly sales and profit goals for the
continued success of each unit under my
supervision.
Specialties: P&L /
Inventory & Cost Control / Performance Management
/ Store Design / Labor Management / Recruiting /
Retention / Procurement / Customer Satisfaction /
Training & Development / Sales Management / Turn
around of struggling units.

Dr. David Wolitzky
Dr. Wolitzky received his BA from The City College of New York (1957) and his Ph.D. in Clinical Psychology from the University of Rochester (1961). He is also a… Dr. Wolitzky received his BA from The City College of New York (1957) and his Ph.D. in Clinical Psychology from the University of Rochester (1961). He is also a graduate of the New York Psychoanalytic Institute (1972). Since 1974 Dr. Wolitzky has been a tenured faculty member in the Department of Psychology, New York University. His many years there of teaching, research, supervisory, and administrative experience included serving as the Director of the Clinical Psychology Ph.D. Program, the N.Y.U Psychology Clinic, and as a Co-Director of the N.Y.U. Postdoctoral Program in Psychotherapy and Psychoanalysis and as a supervisor of candidates in training. His other professional activities include publication of numerous articles and book chapters, edited books, forensic evaluation in child custody cases, psychological assessments of individuals being considered for high-level executive positions in industry, extensive experience as a book editor, and the practice of psychotherapy. He also has served on the New State Board of Psychology, Office of Professional Discipline.
Advisory Board

General Fogleman
General Ronald R. Fogleman (“General Fogleman”) is a
highly decorated combat veteran who retired from the
United States Air Force (“U.S. Air Force”…
General Ronald R. Fogleman (“General Fogleman”) is a
highly decorated combat veteran who retired from the
United States Air Force (“U.S. Air Force” or “USAF”)
after 34 years active commissioned service. On his
final tour of duty he served as the 15th Chief of
Staff of the U.S. Air Force and a member of the Joint
Chiefs of Staff (“JCS”) during the administration of
President Clinton. Prior to that assignment he was
Commander in Chief of the United States Transportation
Command (“CINCTRANS”). As Chief of Staff, he served as
the senior uniformed officer responsible for the
organization, training and equipage of 750,000 active
duty, Guard, Reserve and civilian forces serving in
the United States and Overseas. As a member of the
JCS, he served as a military advisor to the Secretary
of Defense, the National Security Council and the
President. Since retiring from the U.S. Air Force,
General Fogleman has served on the Defense Policy
Board, The National Aeronautics and Space
Administration (“NASA”) Advisory Council, the Jet
Propulsion Laboratory Advisory Board, chaired an Air
Force Laboratory study on directed energy weapons,
chaired a National Resource Committee on Aeronautics
Research and Technology for Vision 2050: An integrated
Transportation System, served on the NASA Mars Program
Independent Assessment Team, the congressionally
directed Commission to Assess United States National
Security Space Management and Organization, the NASA
Shuttle Return to Flight Task Group and the
Independent Assessment Panel to examine the Management
and Organization of National Security Space Assets.
General Fogleman has served on and chaired
several public and private company boards. He is
currently the Chairman of the Board of Alliant
Techsystems Inc. (NYSE: ATK), the Lead Director on the
Board of Directors for AAR Corp. (NYSE: AIR), and
serves on the boards of AGC Composites and
Aerostructures, First National Bank of Durango, MITRE
Corporation, Tactical Air Support, Inc. and
Thayles-Raytheon Systems. he has served as the chair
of Audit and Governance Committees throughout his
career in the public and private sectors.
He devotes considerable time to national
security, governance of public companies and community
affairs. He is a member of the National Association of
Corporate Directors, Council on Foreign Relations,
Falcon Foundation, Airlift Tanker Association, Fort
Lewis College Foundation, and the Air Force
Association. He lectures on leadership, international
affairs and military issues and has published numerous
articles on air and space operations.